default author photo

Kaoru Morita

Jichi Medical University - Division of Hematology

SCHOLARLY PAPERS

1

DOWNLOADS

91

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/ Refractory Multiple Myeloma

Number of pages: 38 Posted: 22 Feb 2023
Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology, Jichi Medical University - Division of Hematology and Jichi Medical University - Division of Hematology
Downloads 91 (742,061)

Abstract:

Loading...

Multiple myeloma, cost-effectiveness analysis, anti-BCMA CAR-T